Anti-viral lotion tissue and methods for making and using the same

Abstract

A soothing anti-viral lotion composition and a lotioned tissue product having a surface with the lotion composition applied thereto, and methods for making and using the same. The lotion composition includes an anti-viral organic acid and a topical delivery system. The topical delivery system includes one or more hydroxyl-functional polyester diols which allow incorporation of the organic acids into the lotion formulation, controls their delivery, and maintains them in the stratum corneum. The lotion composition may optionally contain a surfactant, an irritation inhibiting agent, and other additives.

1 . A non-irritating anti-viral lotioned tissue product having applied to at least one surface thereof an anti-viral lotion composition comprising: 
 a virucidal effective amount of at least one anti-viral organic acid;    a topical delivery system including at least one hydroxy-functional polyester diol.    
   
   
       2 . The lotioned tissue product of  claim 1 , wherein said lotion composition comprises from about 1% to about 25% of said anti-viral organic acid.  
   
   
       3 . The lotioned tissue product of  claim 2 , wherein said at least one anti-viral organic acid comprises at least one member from the group consisting of carboxylic acids having the structure R—COOH, wherein R is a C 1 -C 6  alkyl; C 1 -C 6  alkyl carboxy; C 1 -C 6  alkyl carboxyhydroxy; C 1 -C 6  alkyl carboxy halo; C 1 -C 6  alkylcarboxy dihydroxy; C 1 -C 6  alkyl dicarboxyhydroxy; C 1 -C 6  alkenyl; C 1 -C 6  alkenyl carboxy; C 1 -C 6  alkenyl phenyl; or substituted phenyl radical.  
   
   
       4 . The lotioned tissue product of  claim 3 , wherein one or more hydrogen atoms of R is substituted with a functional group selected from the group consisting of halogen atoms, hydroxyl groups, amino groups, thiol groups, nitro groups, and cyano groups.  
   
   
       5 . The lotioned tissue product of  claim 3 , wherein said at least one anti-viral acid is selected from the group consisting of citric acid, malic acid, adipic acid, glutaric acid, succinic acid, and mixtures thereof.  
   
   
       6 . The lotioned tissue product of  claim 2 , wherein said at least one hydroxy-functional polyester diol comprises trimethylpentanediol/apidic acid copolymer.  
   
   
       7 . The lotioned tissue product of  claim 1 , wherein the lotion composition further comprises a surfactant.  
   
   
       8 . A lotioned tissue product having applied to at least one surface thereof an anti-viral lotion composition comprising: 
 about 1% to about 25% of at least one anti-viral organic acid;    about 5% to about 25% of an emollient including at least one hydroxyl-functional polyester diol; and    a cationic surfactant.    
   
   
       9 . The lotioned tissue product of  claim 8 , wherein said cationic surfactant comprises a quaternary ammonium compound.  
   
   
       10 . A non-irritating, anti-viral lotion composition comprising: 
 a virucidal effective amount of at least one anti-viral organic acid; and    a topical delivery system including at least one hydroxyl-functional polyester diol.    
   
   
       11 . The lotion composition of  claim 10 , wherein said lotion composition comprises from about 1% to about 25% of said anti-viral organic acid.  
   
   
       12 . The lotion composition of  claim 11 , wherein said at least one anti-viral organic acid comprises at least one member from the group consisting of carboxylic acids having the structure R—COOH, wherein R is a C 1 -C 6  alkyl; C 1 -C 6  alkyl carboxy; C 1 -C 6  alkyl carboxyhydroxy; C 1 -C 6  alkyl carboxy halo; C 1 -C 6  alkylcarboxy dihydroxy; C 1 -C 6  alkyl dicarboxyhydroxy; C 1 -C 6  alkenyl; C 1 -C 6  alkenyl carboxy; C 1 -C 6  alkenyl phenyl; or substituted phenyl radical.  
   
   
       13 . The lotion composition of  claim 12 , wherein one or more hydrogen atoms of R is substituted with a functional group selected from the group consisting of halogen atoms, hydroxyl groups, amino groups, thiol groups, nitro groups, and cyano groups.  
   
   
       14 . The lotion composition of  claim 12 , wherein said at least one anti-viral acid is selected from the group consisting of citric acid, malic acid, adipic acid, glutaric acid, succinic acid, and mixtures thereof.  
   
   
       15 . The lotion composition of  claim 11 , wherein said at least one hydroxy-functional polyester diol comprises trimethylpentanediol/apidic acid copolymer.  
   
   
       16 . The lotion composition of  claim 10 , wherein the lotion composition further comprises a surfactant.  
   
   
       17 . The lotion composition of  claim 16 , wherein said surfactant comprises a cationic surfactant.  
   
   
       18 . An anti-viral lotion composition comprising: 
 about 1% to about 25% of at least one anti-viral organic acid;    about 5% to about 25% of an emollient including at least one hydroxyl-functional polyester diol; and    a cationic surfactant.    
   
   
       19 . The lotion composition of  claim 18 , wherein said cationic surfactant comprises a quaternary ammonium compound.  
   
   
       20 . A method of inhibiting the transfer of a viral infection comprising: 
 providing anti-viral lotion tissue product having applied to at least one surface thereof an anti-viral lotion composition comprising a virucidal effective amount of at least one anti-viral organic acid and a topical delivery system including at least one hydroxyl-functional polyester diol;    contacting a fluid containing at least one virus with said anti-viral tissue product; and    absorbing said fluid within said absorbent article to contact the fluid with said anti-viral lotion composition.    
   
   
       21 . The method of  claim 20 , further comprising: 
 transferring a portion of the lotion composition to the user of the tissue product.    
   
   
       22 . A method of making an anti-viral tissue product comprising: 
 heating a composition comprising an a virucidal effective amount of at least one anti-viral organic acid at least one hydroxy-functional polyester diol, at least one oil and at least one wax to a temperature above the melting point of the composition, causing said composition to melt, said composition having a melting point of from about 30° C. to about 70° C.;    uniformly applying the melted composition to at least one surface of a tissue web in spaced-apart deposits; and    resolidifying the deposits of the melted composition.    
   
   
       23 . The method of  claim 22  wherein the heated composition is applied to the tissue web with a gravure printer.  
   
   
       24 . The method of  claim 22  wherein the tissue web is cooled before or after the deposits of the coating composition are applied in order to accelerate solidification of the deposits.  
   
   
       25 . The method of  claim 22  wherein the tissue product is a facial tissue.